Efficacy of Ipragliflozin Compared With Sitagliptin in Uncontrolled Type 2 Diabetes With Sulfonylurea and Metformin
Phase of Trial: Phase III
Latest Information Update: 02 May 2017
At a glance
- Drugs Ipragliflozin (Primary) ; Sitagliptin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 25 Apr 2017 Planned primary completion date changed from 1 Oct 2017 to 1 Oct 2018.
- 25 Apr 2017 Status changed from not yet recruiting to recruiting.
- 15 Mar 2017 New trial record